Showing 1 to 12 of 69 results


Russian Scientists Make Breakthroughs in Cancer Treatment and Rare Disease Therapies
Over the past 10 years, a Russian research center has made significant advancements, including developing new cancer therapies, synthesizing expensive rare disease drugs faster than foreign competitors, and creating AI programs to expedite vaccine development.
Russian Scientists Make Breakthroughs in Cancer Treatment and Rare Disease Therapies
Over the past 10 years, a Russian research center has made significant advancements, including developing new cancer therapies, synthesizing expensive rare disease drugs faster than foreign competitors, and creating AI programs to expedite vaccine development.
Progress
60% Bias Score


Global Cancer Research Funding: A Disparity in Investment
A study in The Lancet Oncology reveals that while \$51.4 billion was invested globally in cancer research between 2016 and 2023, funding disparities exist between high-income and low-income countries, with the US contributing the most and low-income countries receiving only \$48.4 million.
Global Cancer Research Funding: A Disparity in Investment
A study in The Lancet Oncology reveals that while \$51.4 billion was invested globally in cancer research between 2016 and 2023, funding disparities exist between high-income and low-income countries, with the US contributing the most and low-income countries receiving only \$48.4 million.
Progress
16% Bias Score


EU Contributes Significantly to Global Cancer Research Funding
A new analysis reveals the European Union provided 16.8% of global public and philanthropic cancer research funding between 2016 and 2023, totaling \$7.4 billion, while the United States contributed the most at 57%.
EU Contributes Significantly to Global Cancer Research Funding
A new analysis reveals the European Union provided 16.8% of global public and philanthropic cancer research funding between 2016 and 2023, totaling \$7.4 billion, while the United States contributed the most at 57%.
Progress
20% Bias Score


New Blood Test Shows High Accuracy in Detecting Early-Stage Ovarian Cancer
A new blood test for ovarian cancer, developed by AOA Dx and tested on 832 samples, demonstrates 91-93% accuracy in detecting the disease at early stages, using machine learning to analyze blood markers for lipids and proteins, potentially revolutionizing diagnosis and improving patient outcomes.
New Blood Test Shows High Accuracy in Detecting Early-Stage Ovarian Cancer
A new blood test for ovarian cancer, developed by AOA Dx and tested on 832 samples, demonstrates 91-93% accuracy in detecting the disease at early stages, using machine learning to analyze blood markers for lipids and proteins, potentially revolutionizing diagnosis and improving patient outcomes.
Progress
44% Bias Score


Uneven Progress in Cancer Survival Rates Highlights Disparities
A study reveals uneven progress in cancer survival rates over 50 years, with some cancers like melanoma showing 90%+ 10-year survival, while others, including pancreatic, oesophageal, stomach, and lung cancers, lag significantly behind, highlighting disparities in detection and treatment.
Uneven Progress in Cancer Survival Rates Highlights Disparities
A study reveals uneven progress in cancer survival rates over 50 years, with some cancers like melanoma showing 90%+ 10-year survival, while others, including pancreatic, oesophageal, stomach, and lung cancers, lag significantly behind, highlighting disparities in detection and treatment.
Progress
44% Bias Score


€3.1 Million Grant to Revolutionize Cancer Treatment via Targeted Nanomedicine Delivery
Jesús Santamaría, a Spanish chemical engineer, received a €3.1 million grant to improve cancer treatment by addressing the challenge of delivering nanomedicines to tumors, using a novel 'Trojan Horse' strategy.
€3.1 Million Grant to Revolutionize Cancer Treatment via Targeted Nanomedicine Delivery
Jesús Santamaría, a Spanish chemical engineer, received a €3.1 million grant to improve cancer treatment by addressing the challenge of delivering nanomedicines to tumors, using a novel 'Trojan Horse' strategy.
Progress
36% Bias Score

American Pilot Released After Antarctic Detainment
American pilot Ethan Guo, 20, was released from a Chilean air base in Antarctica after a two-month detainment for illegally landing his plane, and has been ordered to pay a $30,000 donation and banned from entering Chile for three years.

American Pilot Released After Antarctic Detainment
American pilot Ethan Guo, 20, was released from a Chilean air base in Antarctica after a two-month detainment for illegally landing his plane, and has been ordered to pay a $30,000 donation and banned from entering Chile for three years.
Progress
16% Bias Score

EU Contributes Significantly to Global Cancer Research Funding
A new study reveals that the European Union provided 16.8% of global public and philanthropic cancer research funding between 2016 and 2023, totaling \$7.4 billion, while the United States contributed the most at 57%.

EU Contributes Significantly to Global Cancer Research Funding
A new study reveals that the European Union provided 16.8% of global public and philanthropic cancer research funding between 2016 and 2023, totaling \$7.4 billion, while the United States contributed the most at 57%.
Progress
12% Bias Score

Chinese Researcher Busted for Smuggling Cancer Research Data to China
On July 9th, a Chinese researcher at MD Anderson Cancer Center in Texas, Yunhai Li, was arrested for attempting to smuggle cancer research data funded by US government agencies to China via his personal Google Drive and a Chinese server; he faces up to 10 years in prison.

Chinese Researcher Busted for Smuggling Cancer Research Data to China
On July 9th, a Chinese researcher at MD Anderson Cancer Center in Texas, Yunhai Li, was arrested for attempting to smuggle cancer research data funded by US government agencies to China via his personal Google Drive and a Chinese server; he faces up to 10 years in prison.
Progress
60% Bias Score

Knights Donate $2 Billion to Oregon Health & Science University
Phil and Penny Knight donated $2 billion to Oregon Health & Science University's Knight Cancer Institute, the largest individual university donation in US history, to double its size and enhance cancer research and treatment, exceeding Michael Bloomberg's 2018 $1.8 billion donation to Johns Hopkins.

Knights Donate $2 Billion to Oregon Health & Science University
Phil and Penny Knight donated $2 billion to Oregon Health & Science University's Knight Cancer Institute, the largest individual university donation in US history, to double its size and enhance cancer research and treatment, exceeding Michael Bloomberg's 2018 $1.8 billion donation to Johns Hopkins.
Progress
32% Bias Score

American Teen Detained in Antarctica for Unauthorized Landing
Nineteen-year-old Ethan Guo, attempting a solo round-the-world flight to raise money for cancer research, was arrested in a Chilean-controlled zone of Antarctica for providing false flight information; after six weeks of detention, he must donate $30,000 to a children's cancer charity to avoid prose...

American Teen Detained in Antarctica for Unauthorized Landing
Nineteen-year-old Ethan Guo, attempting a solo round-the-world flight to raise money for cancer research, was arrested in a Chilean-controlled zone of Antarctica for providing false flight information; after six weeks of detention, he must donate $30,000 to a children's cancer charity to avoid prose...
Progress
48% Bias Score

Stage Three Bowel Cancer Diagnosis Highlights Rise in Early-Onset Cases
Victoria Collins, a 40-year-old from Scotland, was diagnosed with stage three bowel cancer after experiencing symptoms initially mistaken for IBS; this highlights a concerning rise in early-onset bowel cancer cases among younger adults.

Stage Three Bowel Cancer Diagnosis Highlights Rise in Early-Onset Cases
Victoria Collins, a 40-year-old from Scotland, was diagnosed with stage three bowel cancer after experiencing symptoms initially mistaken for IBS; this highlights a concerning rise in early-onset bowel cancer cases among younger adults.
Progress
52% Bias Score
Showing 1 to 12 of 69 results